Investors’ shareholding will increase after receiving bonus shares. While the share price might drop slightly, the overall value of their investment will mostly stay the same.
The bonus shares will have a face value of ₹5, the same as the existing shares.
These shares will be issued in a 1:1 ratio, meaning investors will get the same number of bonus shares as they currently hold.
These shares will be fully paid-up and come with all the rights.
This update has been shared with both the BSE and NSE. The company’s NSE code is ANUHPHR and its BSE code is 506260.
Bonus for Demat Account Holders:
If you hold shares in demat form through NSDL or CDSL, the bonus shares will automatically be credited to your demat account.
This bonus issue reflects the company’s growth and its decision to reward shareholders. If you are an investor, make sure to note the record date – July 15.
About ANUH PHARMA LIMITED
ANUH PHARMA LIMITED is a pharmaceutical company based in India that mainly produces Active Pharmaceutical Ingredients (APIs).
APIs are the raw materials used to make medicines. The company was founded in 1960 by the late freedom fighter Shri Jaywantrai Ji Shah.
ANUH PHARMA creates the core ingredients that make medicines work. For example, Paracetamol contains an API that helps reduce fever.
The company exports its APIs to regions like the USA, Europe, Latin America, the Middle East, Asia, and also supplies the Indian market.
It focuses on APIs used in antibiotics, anti-malarial, cardiovascular, and anti-tuberculosis medicines.
Its manufacturing unit is located in Maharashtra and meets global quality standards like WHO-GMP (World Health Organization – Good Manufacturing Practices) and EDQM (European Directorate for the Quality of Medicines).
